Track startup funding.
Find the investors behind it.
A practical, source-backed view of funding rounds, VC firms, and the companies they back — built for faster founder and investor research.
Coverage snapshot
Know what’s in the dataset.
A growing research layer across funds, companies, and source-backed venture coverage.
673
VC firms
Profiles with stage, focus, and contact links.
1,852
Startups
Companies appearing in our funding coverage.
3
Latest signals
Fund closes and rounds in the investment feed.
1,327
Research articles
Analysis, explainers, and market roundups.
Latest funding & fund-close signals
A date-first view of the newest entries in the Venture Capital Tracker feed. Open each item for the full context and source trail.
BOB raises $5.5M seed led by Mischief
BOB AI Holdings Corp announced $5.5M in seed funding led by Mischief in an October 23, 2026 release, following an October 22 founder interview. Other named participants were Peter Thiel, Codie Sanchez, Mark Pincus and Karman Ventures. Proceeds support product development, onboarding and hiring in Miami. Valuation, individual allocations and exact legal closing date were undisclosed. BOB is a fintech, not a bank.
Star Therapeutics announces $200M private financing
Star Therapeutics announced $200M in private financing on October 23, 2026, co-led by OrbiMed and Janus Henderson Investors, to advance preclinical programs and expand its pipeline. A lettered series and valuation were not disclosed. An unnamed sovereign wealth fund also participated. This is separate from Incyte's July acquisition of Vega; acquisition proceeds and contingent milestones are excluded.
Pathos AI closes $237M Series E led by Bristol Myers Squibb
Company-confirmed $237M Series E close at an approximately $3B post-money valuation. Bristol Myers Squibb led with unnamed existing investors. Separate Pathos payments to Tempus of up to $55M over five years are data-license costs, not financing proceeds. Announced October 23, 2026; individual investor allocations undisclosed.
Research desk
Latest venture capital research
Star Therapeutics Raises $200M After Vega Sale
OrbiMed and Janus Henderson co-led Star Therapeutics’ $200M private financing after the Vega sale. What the new preclinical pipeline still has to prove.
Read articleCoast Raises $35M to Expand Beyond Fuel Cards
Thomvest led Coast's growth-equity round as Intuit Ventures joined. The fleet-finance platform is adding vendor payments, with separate pricing and a bigger adoption test.
Read articleFlapping Airplanes Raises $1B to Make AI More Efficient
Index and Lux co-led the AI lab's $1B Series A. Here is its chip-efficiency strategy, the reported $6B valuation and the commercial proof still needed.
Read articleXona Raises $250M at $2.45B to Expand Its GPS Alternative
Future Ventures led Xona's $250M Series D. Its Pulsar network is moving toward customer service, with farm-robot tests showing both the opportunity and the work ahead.
Read articleGo deeper
Research the market your way.
Use the structured pages when you need a shortlist, a company read, or a plain-English answer about how venture capital works.